Published in Hum Mol Genet on December 08, 2015
Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition. Eur J Hum Genet (2016) 0.87
Novel compound heterozygous ASXL3 mutation causing Bainbridge-ropers like syndrome and primary IGF1 deficiency. Int J Pediatr Endocrinol (2017) 0.75
Hyperventilation-athetosis in ASXL3 deficiency (Bainbridge-Ropers) syndrome. Neurol Genet (2017) 0.75
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res (2011) 30.20
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res (2013) 15.13
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
The mutational landscape of lethal castration-resistant prostate cancer. Nature (2012) 11.82
Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics (2006) 11.33
The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24
Role of histone H2A ubiquitination in Polycomb silencing. Nature (2004) 9.48
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature (2006) 9.20
A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med (2011) 8.26
Melanoma genome sequencing reveals frequent PREX2 mutations. Nature (2012) 7.77
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
A systems biology approach for pathway level analysis. Genome Res (2007) 6.95
Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol (2007) 6.30
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer (2010) 6.27
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol (2011) 6.23
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature (2010) 5.23
The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer (2012) 4.97
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol (2009) 4.18
De novo mutations in human genetic disease. Nat Rev Genet (2012) 3.81
Transcriptional regulation by Polycomb group proteins. Nat Struct Mol Biol (2013) 2.96
On ontologies for biologists: the Gene Ontology--untangling the web. Novartis Found Symp (2002) 2.94
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet (2013) 2.44
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell (2012) 2.42
Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect Immun (1990) 2.40
Onto-Tools: new additions and improvements in 2006. Nucleic Acids Res (2007) 2.33
Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell (2009) 2.21
De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome. Genome Med (2013) 2.03
The genetic basis of myelodysplasia and its clinical relevance. Blood (2013) 1.95
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun (2014) 1.90
Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation. Mol Cell (2013) 1.86
The PHD finger: a versatile epigenome reader. Trends Biochem Sci (2011) 1.81
Comparison of germline mosaics of genes in the Polycomb group of Drosophila melanogaster. Genetics (1995) 1.72
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med (2013) 1.71
A genetic screen identifies novel polycomb group genes in Drosophila. Genetics (2007) 1.60
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol (2012) 1.56
Histone H2A mono-ubiquitination is a crucial step to mediate PRC1-dependent repression of developmental genes to maintain ES cell identity. PLoS Genet (2012) 1.40
Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor. J Biol Chem (2006) 1.37
Tn5 transposase and tagmentation procedures for massively scaled sequencing projects. Genome Res (2014) 1.33
Functional conservation of Asxl2, a murine homolog for the Drosophila enhancer of trithorax and polycomb group gene Asx. PLoS One (2009) 1.32
Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice. Dev Biol (2009) 1.30
Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet (2013) 1.22
Functional and cancer genomics of ASXL family members. Br J Cancer (2013) 1.21
Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family. Gene (2006) 1.16
The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications. Cell Cycle (2012) 1.14
Usp16 contributes to somatic stem-cell defects in Down's syndrome. Nature (2013) 1.13
An AUTS2-Polycomb complex activates gene expression in the CNS. Nature (2014) 1.12
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations. J Clin Invest (2013) 1.12
Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability. PLoS One (2010) 1.12
Establishment and culture of human skin fibroblasts. Curr Protoc Mol Biol (2005) 1.11
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. Blood (2014) 1.10
A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry (2012) 1.09
Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation. Am J Hum Genet (2015) 1.09
Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Eur J Hum Genet (2012) 1.03
De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies. BMC Med Genomics (2013) 0.98
Human HOX gene disorders. Mol Genet Metab (2013) 0.92
Mutation in PHC1 implicates chromatin remodeling in primary microcephaly pathogenesis. Hum Mol Genet (2013) 0.92
Genome-wide co-localization of Polycomb orthologs and their effects on gene expression in human fibroblasts. Genome Biol (2014) 0.90
The histone H2A deubiquitinase Usp16 regulates embryonic stem cell gene expression and lineage commitment. Nat Commun (2014) 0.90
Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine. Expert Rev Proteomics (2015) 0.88
Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution. Br J Haematol (2014) 0.87
Epigenetic alterations in acute myeloid leukemias. FEBS J (2014) 0.85
Expanding our knowledge of conditions associated with the ASXL gene family. Genome Med (2013) 0.83
Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21). Leuk Lymphoma (2015) 0.78
Developing classifiers for the detection of cancer using multi-analytes. Methods Mol Biol (2009) 0.76
Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets. PLoS One (2013) 0.76